Human glutathione S-transferase A1, T1, M1, and P1 polymorphisms and susceptibility to prostate cancer in the Japanese population
- First Online:
- 124 Downloads
Purpose: The incidence of prostate cancer is increasing in low-risk populations such as Japanese. One of the causes of this increase is considered to be associated with the Western diet, especially the high intake of red meat and fat. Glutathione S-transferase (GST) A1, T1, M1, and P1 are phase II enzymes that are important for activation and detoxification of chemical carcinogens.
Methods: In this study, 190 Japanese male patients with prostate cancer and 294 healthy controls, frequency-matched for age, were compared for frequencies of GSTA1, GSTT1, GSTM1, and GSTP1 genotypes.
Results: Among smokers, the frequency of the GSTA1*A/*B or *B/*B genotype in patients with prostate cancer (27.8%) showed a statistically significant increase compared with the control group frequency (18.2%; odds ratio [OR] =1.72; 95% CI, 1.01–2.94). In addition, the frequency of GSTT1 nondeletion genotype was associated with prostate cancer among smokers (OR =1.68; 95% CI, 1.06–2.68). The OR of carrying the combined genotyping of GSTA1*A/*B or *B/*B and GSTT1 nondeletion was 2.08 (95% CI, 1.14–3.80) with the combined genotyping of GSTA1*A/*A and GSTT1 null as a reference. On the other hand, no significant associations were observed for genotypes of GSTM1 and GSTP1 I105V.
Conclusions: These findings suggest that the GSTA1 and GSTT1 polymorphisms are associated with prostate cancer susceptibility, especially among smokers.
KeywordsGSTA1 GSTT1 Polymorphism Prostate cancer
- Coles BF, Morel F, Rauch C, Huber WW, Yang M, Teitel CH, Green B, Lang NP, Kadlubar FF (2001) Effect of polymorphism in the human glutathione S-transferase A1 promotor on hepatic GSTA1 and GSTA2 expression. Pharmacogenetics 11:663–669Google Scholar
- Guengerich FP, Thier R, Persmark M, Taylor JB, Pemple SE, Ketterer B (1995) Conjugation of carcinogens by theta class glutathione S-transferase: mechanisms and relevance to variations in human risk. Pharmacogenetics 5:S103–S107Google Scholar
- Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF (1994) Effect of human and rat glutathione S-transferase on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis. Cancer Res 54:4920–4926PubMedGoogle Scholar
- Morel F, Rauch C, Coles B, Ferrec EL, Guillouzo A (2002) The human glutathione transferase alpha locus: genomic organization of the gene cluster and functional characterization of the genetic polymorphism in the hGSTA1 promotor. Pharmacogenetics 12:277–286Google Scholar
- Murata M, Wtanabe M, Yamanaka M, Kubota Y, Itoh H, Nagao M, Katoh T, Kamataki T, Kawanura J, Yatani R, Shiraishi T (2001) Genetic polymorphisms in cytochrome P450 (CYP)1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population. Cancer Lett 165:171–177PubMedGoogle Scholar
- Nelson CP, Kidd CR, Sauvageot J, Isaacs WB, De Marzo AM, Groopman JD, Nelson WG, Kensler TW (2001) Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1. Cancer Res 61:103–109PubMedGoogle Scholar
- Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, New York, pp 9.1–9.62Google Scholar
- Seidegard J, Vorachek WR, Pero RW (1998) Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to gene deletion. Proc Natl Acad Sci USA 85:7293–7297Google Scholar
- Shirai T, Sano M, Tamano S, Takahashi S, Hirose M, Futakuchi M, Hasegawa R, Imaida K, Matsumoto K, Wakabayashi K, Sugimura T, Ito N (1997) The prostate: a target for carcinogenicity of 2-amino-1-metyl-6-phenylimidazo[4,5-b]pyridine(PhIP) derived from cooked foods. Cancer Res 57:195–198PubMedGoogle Scholar